The Effect of Kombucha on Blood Sugar Levels in Humans

Glucose Metabolism Disorders (Including Diabetes Mellitus) Clinical Trial

Official title: A Clinical Trial to Measure the Biochemical Response of Kombucha Tea in Humans

Status Completed

Clinical Trial Summary

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

Clinical Trial Description

Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp & Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market. As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study. This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm. Arms (at least 5 subjects in each arm, minimum total=20 subjects) 1. Intervention group 1: commercial kombucha: drink 8oz kombucha 2. Intervention group 2: brewed kombucha: drink 8oz kombucha 3. Control group: drink 8oz tea (the same type as used to brew the kombucha) 4. Control group 2: drink 8oz tap water ;

Related Conditions & MeSH terms

• Blood Sugar; High
• Glucose
• Glucose Metabolism Disorders
• Glucose Metabolism Disorders (Including Diabetes Mellitus)
• Hyperglycemia
• Metabolic Diseases

• NCT number: NCT04051294
• Study type: Interventional
• Source: University of Missouri-Columbia
• Status: Completed
• Phase: N/A
• Start date: January 3, 2019
• Completion date: September 30, 2022